Skip to main content
    E

    Ensysce Biosciences Inc (ENSC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.38
    -0.03 (-6.28%)

    Market Cap: $7.97M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Ensysce Biosciences Inc (ENSC) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Ensysce Biosciences (ENSC) has a latest price of $0.38 on Nov 17, 2026, 80.3% below its 52-week high of $1.95. Its price fell 81.4% over the past 12 months. The month-end price fell 100.0% since Mar 2018, a compound annual decline of 73.2%.

    Price Chart

    From Mar 2018 to Oct 2026, its highest month-end close was $52,158.79 in Jun 2021 and its lowest $0.25 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ENSC with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENSC.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 1.1%, and over 6 months it rose 29.5%. The month-end price fell 97.0% over the 3 years through Oct 2026, a compound annual decline of 68.8%.

    PeriodChange
    1 month-23.7%
    3 months-1.1%
    6 months+29.5%
    12 months-81.4%
    12 months, with dividends-81.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-97.0%-68.8%
    5 years-100.0%-86.0%
    Since Mar 2018-100.0%-73.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 19.3%, and its weakest was 2022, when it fell 99.2%.

    YearCloseChange
    2026 through Oct 2026$0.42-54.2%
    2025$0.92-88.7%
    2024$8.14-48.8%
    2023$15.89-88.2%
    2022$134.99-99.2%
    2021$16,918.31-62.2%
    2020$44,760.45+19.3%
    2019$37,508.26+6.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 13.4% below its 50-day average of $0.44 and 5.1% below its 200-day average of $0.40.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.38
    52-week high$1.95-80.3%
    52-week low$0.23+66.9%
    50-day average$0.44-13.4%
    200-day average$0.40-5.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.0%.

    MeasureValue
    1-year beta1.33
    Largest fall, 1 year-87.2%
    Largest fall, 3 years-99.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ENSC

    What is ENSC's 1-year price change?

    Ensysce Biosciences's price fell 81.4% over the past 12 months. With dividends included, the 12-month total return was -81.4%.

    What is ENSC's 5-year price change?

    Ensysce Biosciences's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 86.0%. These figures leave out dividends.

    What is ENSC's 52-week high and low?

    Ensysce Biosciences's 52-week high is $1.95 and its 52-week low is $0.23. Its latest price of $0.38 on Nov 17, 2026 is 80.3% below the high.

    What is ENSC's beta?

    Ensysce Biosciences's 1-year beta against the S&P 500 is 1.33, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.2%.

    Is the ENSC chart free?

    Yes. Advanced Charting for ENSC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.